- 201. Breast Apocrine Adenoma
- (UMLS (NCI) C1388299) =Neoplastic Process ;
| - 251. Breast engorgement in newborn
- (UMLS (ICD9CM) C1449721) NB BREAST ENGORGEMENT;
=Disease or Syndrome ;
|
- 202. Breast Cancer
- [(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. ( NCI )] (UMLS (NCI) C0678222) =Neoplastic Process ;
| - 252. Breast Epithelial Antigen BA46
- [Expressed in mammary epithelia and activated macrophages by human MFGE8 Gene, 387-aa 43-kDa (precursor) Milk Fat Globule-EGF Factor 8 Protein is a multidomain cell surface (and secreted) protein that contains an EGF-like domain, C-terminal F5/8 type C domains, and the cell adhesion tripeptide RGD. MFGE8 recognizes aminophospholipids (phosphatidylserine) and binds to cells via its RGD motif; MFGE8 binds strongly to cells expressing alpha-V-beta-3 integrin. Expressed by activated macrophages, MFGE8 specifically binds to apoptotic cells and appears to promote macrophage phagocytosis of apoptotic cells. MFGE8 is overexpressed in several carcinomas. (NCI) ( NCI )] (UMLS (NCI) C0388561) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 203. Breast Cancer Antigen 84 NY-BR-84 Protein
- [Encoded by human NY-BR-84 Gene, the widely expressed 383-amino acid 43 kD NY-BR-84 Protein has an unknown function and sequence similarity to acyl-CoA thioesterase (C. elegans) and serologically defined breast cancer antigen 84 (Mouse). (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1334919) Hypothetical 43.2 kD Protein;
NY-BR-84;
SDBCAG84;
Serologically Defined Breast Cancer Antigen 84;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 253. Breast Epithelial Hyperplasia
- (UMLS (NCI) C0741698) Ductal Breast Hyperplasia;
Ductal Hyperplasia of Breast;
Ductal Hyperplasia of the Breast;
Epithelial Hyperplasia of Breast;
Epithelial Hyperplasia of the Breast =Finding |
- 204. Breast Cancer Antigen NY-BR-20 Protein
- [Encoded by human NY-BR-20 Gene, NY-BR-20 Protein has an unknown function. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1334917) CALML4;
Calmodulin-Like 4;
Calmodulin-Like 4 Protein;
NY-BR-20;
NY-BR-20 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 254. Breast Epithelioid Hemangioma
- [A hemangioma characterized by the presence of epithelioid endothelial cells, arising from the breast. ( NCI )] (UMLS (NCI) C1332627) Breast Histiocytoid Hemangioma;
Epithelioid Breast Hemangioma;
Epithelioid Hemangioma of Breast;
Epithelioid Hemangioma of the Breast;
Histiocytoid Breast Hemangioma;
Histiocytoid Hemangioma of Breast;
Histiocytoid Hemangioma of the Breast =Neoplastic Process ;
|
- 205. breast cancer diagnosis
- [ ] (UMLS (CSP) C0920737) =Diagnostic Procedure ;
| - 255. Breast Extraskeletal Osteosarcoma
- [An osteosarcoma arising from breast tissue. ( NCI )] (UMLS (NCI) C1335149) Breast Osteosarcoma;
Osteogenic Breast Sarcoma;
Osteogenic Sarcoma of Breast;
Osteogenic Sarcoma of the Breast;
Osteosarcoma of Breast;
Osteosarcoma of the Breast =Neoplastic Process ;
|
- 206. Breast Cancer Early Detection
- [Early detection of breast cancer involving asymptomatic women. Generally done in the population with higher risk, due to environmental or genetic factors. ( NCI )] (UMLS (NCI) C0281182) =Therapeutic or Preventive Procedure
| - 256. Breast Fat Necrosis
- (UMLS (NCI) C0156321) =Disease or Syndrome ;
|
- 207. Breast Cancer Estrogen-Inducible Protein
- [Expressed in breast, pancreas, stomach, and gastrointestinal epithelium, estrogen-responsive human TFF1 Gene (Trefoil Family) encodes cysteine-rich secretory 84-aa 9-kD (precursor) PS2 Protein, a likely tumor suppressor containing one P-type trefoil domain and a 40-aa domain with three conserved disulfides. TFF1 appears to play a complex repressor role in cell progression towards S phase (G1/S transition) and in apoptosis; TFF1 may promote cell differentiation and tissue repair. TFF1 may protect the gastrointestinal mucosa from insults, stabilize the mucus layer, and affect epithelial healing; strong expression is found in GI tract regenerative tissues. The exact function of TFF1/PS2 has not yet been determined. (NCI) ( NCI )] (UMLS (NCI) C0072523) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 257. breast feeding
- [nursing of an infant at the mother's breast. ( CSP )] (UMLS (CSP) C0006147) =Organism Function =eating;
Physiologic States |
- 208. Breast Cancer Genetics
- [Breast cancer genetics involve clinical, epidemiologic and/or laboratory evaluations of individuals and their families who are at high risk of developing breast cancer due to hereditary predisposition. These studies are aimed at identifying susceptibility genes for breast cancer and their associated molecular and genetic aberrations, as well as the functions of their encoded proteins. ( NCI )] (UMLS (NCI) C0879255) Breast Cancer, Genetics;
=Biomedical Occupation or Discipline | - 258. Breast Fibroadenoma
- [A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported. ( NCI )] (UMLS (NCI) C0178421) =Neoplastic Process ;
|
- 209. Breast Cancer in situ
- [Abnormal cells that are confined to the ducts or lobules in the breast. There are two forms, called ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). ( NCI )] (UMLS (NCI) C0154084) =Neoplastic Process
| - 259. Breast Fibrocystic Change
- [Fibrosis associated with cyst formation in the breast parenchyma. — 2003 ( NCI )] (UMLS (NCI) C0016034) =Disease or Syndrome =Breast Disease;
cyst |
- 210. Breast Cancer Metastasis Suppressor 1 Gene
- [This gene plays a role in metastasis suppression. ( NCI )] (UMLS (NCI) C1332450) BRMS1;
BRMS1 Gene;
=Gene or Genome ;
| - 260. Breast Fibrocystic Change, Non-Proliferative Type
- (UMLS (NCI) C1332628) Non-Proliferative Fibrocystic Change;
Non-Proliferative Fibrocystic Change of Breast;
Non-Proliferative Fibrocystic Change of the Breast =Disease or Syndrome ;
|
- 211. Breast Cancer Metastasis-Suppressor 1
- [Encoded by human BRMS1 Gene, the widely expressed 28 kD BRMS1 Protein (BRMS1 Family) contains 246 predicted amino acids. BRMS1 may mediate metastasis suppression in breast carcinoma; locally invasive tumors that express BRMS1 are significantly less metastatic to lungs and regional lymph nodes. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0915193) BRMS1;
BRMS1 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 261. Breast Fibrosarcoma
- [A usually aggressive malignant neoplasm arising from the breast. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. ( NCI )] (UMLS (NCI) C1332630) Fibrosarcoma of Breast;
Fibrosarcoma of the Breast;
=Neoplastic Process ;
|
- 212. Breast Cancer Metastatic
- [Cancer has spread to other organs of the body, most often the bones, lungs, liver, or brain; or tumor has spread locally to the skin and lymph nodes inside the neck, near the collarbone. ( NCI )] (UMLS (NCI) C0278488) =Neoplastic Process
| - 262. Breast Fibrosclerosis
- (UMLS (NCI) C0156318) =Disease or Syndrome ;
|
- 213. Breast Cancer Prevention
- [Anything, such as drug administration or lifestyle changes, designed to inhibit the onset of breast cancer. ( NCI )] (UMLS (NCI) C0281189) =Therapeutic or Preventive Procedure
| - 263. Breast fluid
- (UMLS (HL7) C1549096) =Body Substance =Body Part;
|
- 214. Breast Cancer Stage I
- [Cancer no bigger than 2 centimeters (about 1 inch) that has not spread outside the breast. ( NCI )] (UMLS (NCI) C0278485) =Neoplastic Process
| - 264. BREAST FULL-THICK GRAFT
- (UMLS (ICD9CM) C0191939) =Therapeutic or Preventive Procedure
|
- 215. Breast Cancer Stage II
- [Stage II breast cancer means one of the following: cancer is no larger than 2 centimeters but has spread to the lymph nodes in the armpit (the axillary lymph nodes); cancer is between 2 and 5 centimeters (1 to 2 inches) and may have spread to the lymph nodes in the armpit; cancer is larger than 5 centimeters (2 inches) but has not spread to the lymph nodes in the armpit. ( NCI )] (UMLS (NCI) C0278486) =Neoplastic Process
| - 265. Breast Hamartoma
- (UMLS (NCI) C0238032) =Disease or Syndrome ;
|
- 216. Breast Cancer Stage IIA
- (UMLS (NCI) C1336156) Breast Carcinoma Stage IIA;
Stage IIA Breast Cancer;
Stage IIA Breast Carcinoma;
=Neoplastic Process | - 266. Breast Hyperplasia
- (UMLS (NCI) C0542028) =Finding ;
|
- 217. Breast Cancer Stage IIB
- (UMLS (NCI) C1336178) Breast Carcinoma Stage IIB;
Stage IIB Breast Cancer;
Stage IIB Breast Carcinoma =Neoplastic Process | - 267. Breast Hypertrophy
- (UMLS (NCI) C0020565) =Disease or Syndrome
|
- 218. Breast Cancer Stage III
- [Stage III is divided into stages IIIA and IIIB. In stage IIIA breast cancer, the cancer (1) is smaller than 5 centimeters (2 inches) and has spread to the lymph nodes in the armpit, which have grown into each other or into other structures and are attached to them; or (2) is larger than 5 centimeters and has spread to the lymph nodes in the armpit. In stage IIIB breast cancer, the cancer (1) has spread to tissues near the breast (skin, chest wall, including the ribs and the muscles in the chest); or (2) has spread to lymph nodes inside the chest wall along the breast bone. ( NCI )] (UMLS (NCI) C0278487) =Neoplastic Process
| - 268. Breast Imaging Study
- (UMLS (NCI) C1134632) =Diagnostic Procedure
|
- 219. Breast Cancer Stage IIIA
- [Stage IIIA breast cancer is defined by either of the following: (1) the cancer is smaller than 5 centimeters (2 inches) and has spread to the lymph nodes under the arm, which have grown into each other or into other structures and are attached to them; (2) the cancer is larger than 5 centimeters and has spread to the lymph nodes under the arm. ( NCI )] (UMLS (NCI) C0278489) =Neoplastic Process
| - 269. BREAST IMPL REMOV STATUS
- [ ] (UMLS (ICD9CM) C0375853) =Finding
|
- 220. Breast Cancer Stage IIIB
- [Stage IIIB breast cancer is defined by either of the following: (1) the cancer has spread to tissues near the breast (skin, chest wall, including the ribs and the muscles in the chest); (2) the cancer has spread to lymph nodes inside the chest wall along the breast bone. ( NCI )] (UMLS (NCI) C0278513) =Neoplastic Process
| - 270. breast implant
- [implant, often of silicone, in the mammary tissue; may be preformed for medical or cosmetic reasons. ( CSP )] (UMLS (CSP) C0178391) =Therapeutic or Preventive Procedure =implant;
|
- 221. Breast Cancer, Recurrent
- [The reemergence of cancer in the breast after a period of remission ( NCI )] (UMLS (NCI) C0278493) =Neoplastic Process
| - 271. breast implant
- [A silicone gel-filled or saline-filled sac placed under the chest muscle to restore breast shape. ( NCI )] (UMLS (NCI) C0179412) =Medical Device
|
- 222. Breast Cancer-Specific Gene 1 Protein
- [Encoded by human SNCG Gene (Synuclein Family), the highly conserved 127-amino acid 13 kD cytoplasmic Gamma-Synuclein is similar to the amyloid protein nonamyloid beta fragment and to alpha-synuclein and beta-synuclein. SNCG is expressed in brain, heart, skeletal muscle, ovary, testis, colon, spleen, pancreas, kidney and lung. Gamma-Synuclein seems to play a role in neurofilament network integrity and may modulate axonal architecture; it may increase the susceptibility of neurofilament-H to calcium-dependent proteases and may also modulate the keratin network in skin. Phosphorylation by GRK5 appears to occur on residues distinct from other kinase target residues. Gamma-Synuclein is likely involved in the pathogenesis of neurodegenerative diseases and SNCG is expressed at very high level in advanced infiltrating breast cancer. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0753208) Breast Cancer-Specific Protein 1;
Gamma-Synuclein;
Persyn;
SNCG;
Synoretin;
Synuclein Gamma =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 272. BREAST IMPLANT REMOVAL
- (UMLS (ICD9CM) C0191909) =Therapeutic or Preventive Procedure
|
- 223. Breast Capillary Angioma
- [A capillary hemangioma arising from the breast. ( NCI )] (UMLS (NCI) C1332619) Breast Capillary Hemangioma;
Capillary Angioma of Breast;
Capillary Angioma of the Breast;
Capillary Hemangioma of Breast;
Capillary Hemangioma of the Breast =Neoplastic Process ;
| - 273. BREAST IMPLANT REVISION
- (UMLS (ICD9CM) C0191920) =Therapeutic or Preventive Procedure
|
- 224. Breast Carcinoid
- (UMLS (NCI) C1332839) Breast Carcinoid Neoplasm;
Breast Carcinoid Tumor;
Carcinoid Breast Tumor;
Carcinoid Neoplasm of Breast;
Carcinoid Neoplasm of the Breast;
Carcinoid of Breast;
Carcinoid of the Breast;
Carcinoid Tumor of Breast;
Carcinoid Tumor of the Breast;
Mammary Carcinoid Neoplasm;
Mammary Carcinoid Tumor;
Primary Breast Carcinoid Neoplasm;
Primary Breast Carcinoid Tumor;
Primary Carcinoid Breast Tumor;
Primary Carcinoid Neoplasm of Breast;
Primary Carcinoid Neoplasm of the Breast;
Primary Carcinoid Tumor of Breast;
Primary Carcinoid Tumor of the Breast =Neoplastic Process ;
| - 274. BREAST INF NEC-ANTEPART
- [ ] (UMLS (ICD9CM) C0157621) =Disease or Syndrome
|
- 225. Breast Carcinoma Metastatic to the Bone
- (UMLS (NCI) C1332623) =Neoplastic Process ;
| - 275. BREAST INF NEC-DEL W P/P
- [ ] (UMLS (ICD9CM) C0157620) =Disease or Syndrome
|
- 226. Breast Carcinoma Metastatic to the Brain
- (UMLS (NCI) C1332624) =Neoplastic Process ;
| - 276. BREAST INF NEC-POSTPART
- [ ] (UMLS (ICD9CM) C0157622) =Disease or Syndrome
|
- 227. Breast Carcinoma Metastatic to the Liver
- (UMLS (NCI) C1332625) =Neoplastic Process ;
| - 277. BREAST INF NOS-ANTEPART
- [ ] (UMLS (ICD9CM) C0157627) =Disease or Syndrome ;
|
- 228. Breast Carcinoma Metastatic to the Lung
- (UMLS (NCI) C1332626) =Neoplastic Process ;
| - 278. BREAST INF NOS-DEL W P/P
- [ ] (UMLS (ICD9CM) C0157626) =Disease or Syndrome ;
|
- 229. Breast Carcinoma Metastatic to the Skin
- [Cancer that has spread from the breast to the skin. ( NCI )] (UMLS (NCI) C0935909) cutaneous breast cancer;
=Neoplastic Process | - 279. BREAST INF NOS-POSTPART
- [ ] (UMLS (ICD9CM) C0157628) =Disease or Syndrome ;
|
- 230. Breast Carcinoma, Female
- (UMLS (NCI) C0007104) =Neoplastic Process ;
| - 280. BREAST INF PREG NEC-UNSP
- [ ] (UMLS (ICD9CM) C0157618) =Disease or Syndrome
|
- 231. Breast Cell Glutaminase
- [Encoded by human GA Gene, the 602-amino acid 66 kD (precursor) Glutaminase (GA Family) has a putative N-terminal mitochondrial import presequence. Expressed in liver, brain, and pancreas, but not in kidney, heart, skeletal muscle, lung, or placenta, GA protein shares 94% and 72% sequence identity with rat liver and kidney glutaminases, respectively. Containing two ankyrin repeats, human glutaminase is most similar to rat liver-type glutaminase, but is not liver specific. Involved in regulation of glutamine catabolism, mitochondrial glutaminase converts L-glutamine to L-glutamate and NH3. Glutaminase expression and activity depend on the cell proliferation state with highest levels at the beginning of the exponential growth phase. (NCI) ( NCI )] (UMLS (NCI) C0017796) =Amino Acid, Peptide, or Protein; Enzyme ;
=amidinohydrolase;
| - 281. BREAST INF PREG NOS-UNSP
- [ ] (UMLS (ICD9CM) C0157624) =Disease or Syndrome ;
|
- 232. Breast clinic
- (UMLS (HL7) C1552768) =Intellectual Product ;
=Outpatient facility;
| - 282. BREAST INFECT NEC-DELIV
- [ ] (UMLS (ICD9CM) C0157619) =Disease or Syndrome
|
- 233. Breast Comedocarcinoma
- [A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells. ( NCI )] (UMLS (NCI) C1334002) DCIS Grade 3;
DIN 3;
Ductal Intraepithelial Neoplasia, Grade 3;
High Grade Ductal Breast Carcinoma In Situ;
High-Grade DCIS of Breast;
High-Grade DCIS of the Breast;
High-Grade Ductal Carcinoma In Situ of Breast =Neoplastic Process ;
| - 283. BREAST INFECT NOS-DELIV
- [ ] (UMLS (ICD9CM) C0157625) =Disease or Syndrome ;
|
- 234. Breast Cyst
- [A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE. ( MSH )] (UMLS (NCI) C0006144) =Anatomical Abnormality
| - 284. BREAST INJECTION
- (UMLS (ICD9CM) C0191912) =Therapeutic or Preventive Procedure
|
- 235. Breast Cystosarcoma Phyllodes
- [A type of tumor found in breast tissue. It is often large and bulky and grows quickly. It is usually benign (not cancer), but may be malignant (cancer). ( NCI )] (UMLS (NCI) C0238031) =Neoplastic Process ;
| - 285. Breast Leiomyosarcoma
- [An aggressive malignant smooth muscle neoplasm, arising from the breast. It is characterized by a proliferation of neoplastic spindle cells. ( NCI )] (UMLS (NCI) C1332631) Leiomyosarcoma of Breast;
Leiomyosarcoma of the Breast;
=Neoplastic Process ;
|
- 236. breast density
- [relative proportion of fat, connective tissue, and glandular epithelial tissue in the breast; while denser breasts are more difficult to evaluate with mammorgaphy, older women whose mammograms show more dense tissue are at increased risk of breast cancer. ( CSP )] (UMLS (CSP) C1659543) =Clinical Attribute ;
=mammary;
| - 286. Breast Lipoma
- [A common benign adipose tissue neoplasm of the breast occasionally containing entrapped lobular and epithelial elements. ( NCI )] (UMLS (NCI) C0349565) =Neoplastic Process
|
- 237. BREAST DIS NEC-ANTEPART
- [ ] (UMLS (ICD9CM) C0157652) =Disease or Syndrome
| - 287. Breast Liposarcoma
- [A malignant adipose tissue neoplasm of the breast. ( NCI )] (UMLS (NCI) C1332632) Liposarcoma of Breast;
Liposarcoma of the Breast;
=Neoplastic Process ;
|
- 238. BREAST DIS NEC-DEL W P/P
- [ ] (UMLS (ICD9CM) C0157651) =Disease or Syndrome
| - 288. Breast Lump
- [A mass in the mammary gland, either mobile or immobile. Once the mass has reached the size of a small garden pea, it can be detected by palpation. With mammography a larger number of early breast cancers are being detected since this techniques allows detection prior to the point at which the mass can be felt. Breast masses are not always malignant. Benign fibrocystic breast disease is not uncommon. A fine needle biopsy aspiration can distinguish a cystic mass from a solid one. ( NCI )] (UMLS (NCI) C0024103) =Finding ;
|
- 239. BREAST DIS NEC-DELIVERED
- [ ] (UMLS (ICD9CM) C0157650) =Disease or Syndrome
| - 289. Breast MALT lymphoma
- (UMLS (NCI) C1332633) Breast Mucosa-Associated Lymphoid Tissue Lymphoma =Neoplastic Process ;
|
- 240. BREAST DIS NEC-POSTPART
- [ ] (UMLS (ICD9CM) C0157653) =Disease or Syndrome
| - 290. Breast Melanoma
- (UMLS (NCI) C0346787) =Neoplastic Process
|
- 241. BREAST DIS PREG NEC-UNSP
- [ ] (UMLS (ICD9CM) C0157649) =Disease or Syndrome
| - 291. Breast Metastases
- [The spread of cancer to the breast. This may be from a primary breast cancer on the opposite side, or from a cancer at a distant site. ( NCI )] (UMLS (NCI) C0346993) =Neoplastic Process
|
- 242. Breast Disease
- [disease or disorder of the breast. ( CSP )] (UMLS (NCI) C0006145) =Disease or Syndrome =Endocrine Disease;
Genital Disorders =gynecomastia;
breast neoplasm;
Breast Fibrocystic Change;
gynecomastia;
LACTATION DIS NOS-UNSPEC;
breast neoplasm | - 292. Breast Microcalcification
- [(MY-krow-kal-si-fi-KAY-shunz) Tiny deposits of calcium in the breast that cannot be felt but can be detected on a mammogram. A cluster of these very small specks of calcium may indicate that cancer is present. ( NCI )] (UMLS (NCI) C0520594) =Pathologic Function
|
- 243. BREAST DISORDERS NEC
- [ ] (UMLS (ICD9CM) C0156325) =Disease or Syndrome ;
| - 293. Breast Microglandular Adenosis
- (UMLS (NCI) C1334753) Microglandular Adenosis of Breast;
Microglandular Adenosis of the Breast =Disease or Syndrome |
- 244. Breast Duct Lavage
- [A minimally-invasive procedure that permits sampling of breast ductal fluids for cytopathologic analysis. ( NCI )] (UMLS (NCI) C1328067) =Diagnostic Procedure; ;
| - 294. Breast milk
- (UMLS (HL7) C1546712) =Intellectual Product =Specimen Source Codes;
◊ (UMLS (HL7) C1547004) Idea or Concept Indirect exposure mechanism; |
- 245. BREAST DX PROCEDURE NEC
- [ ] (UMLS (ICD9CM) C0177668) =Diagnostic Procedure
| - 295. Breast milk
- (UMLS (HL7) C1556060) =Body Substance =SpecimenEntityType;
|
- 246. BREAST ENGORGE-ANTEPART
- [ ] (UMLS (ICD9CM) C0157646) =Disease or Syndrome
| - 296. Breast Milk
- [white liquid secreted by the human mammary glands; it contains proteins, sugar, lipids, vitamins, and minerals. ( CSP )] (UMLS (NCI) C0026140) =Body Substance =MILK;
Body Part |
- 247. BREAST ENGORGE-DEL W P/P
- [ ] (UMLS (ICD9CM) C0157645) =Disease or Syndrome
| - 297. Breast Mucinous Carcinoma
- [An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin. Pure mucinous breast carcinomas have generally a favorable prognosis. ( NCI )] (UMLS (NCI) C1334807) Colloid Breast Carcinoma;
Colloid Carcinoma of Breast;
Colloid Carcinoma of the Breast;
Infiltrating Colloid Breast Carcinoma;
Infiltrating Mucinous Breast Carcinoma;
Invasive Colloid Breast Carcinoma;
Invasive Mucinous Breast Carcinoma;
Mucinous Breast Carcinoma;
Mucinous Carcinoma of Breast;
Mucinous Carcinoma of the Breast =Neoplastic Process ;
|
- 248. BREAST ENGORGE-DELIVERED
- [ ] (UMLS (ICD9CM) C0157644) =Disease or Syndrome
| - 298. BREAST MUSCLE FLAP GRAFT
- (UMLS (ICD9CM) C0191941) =Therapeutic or Preventive Procedure
|
- 249. BREAST ENGORGE-POSTPART
- [ ] (UMLS (ICD9CM) C0157647) =Disease or Syndrome
| - 299. breast neoplasm
- [new abnormal mammary tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C1458155) Breast Neoplasms;
Breast Tumor;
Mammary Neoplasms;
mammary tumor;
Neoplasm of Breast;
Neoplasm of the Breast;
Neoplasm, breast;
Tumor of Breast;
Tumor of the Breast;
=Neoplastic Process ;
=Breast Disease;
Neoplasm by Site;
Neoplasm of Reproductive System;
breast neoplasm =Mammary Paget's Disease;
Li Fraumeni syndrome;
cystosarcoma phyllodes;
Mammary Neoplasms, Experimental;
Breast Neoplasms, Male;
breast neoplasm |
- 250. BREAST ENGORGE-UNSPEC
- [ ] (UMLS (ICD9CM) C0157643) =Disease or Syndrome
| - 300. breast neoplasm diagnosis
- [ ] (UMLS (CSP) C0920407) =Diagnostic Procedure
|
home
